Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) routine notices

112 filed, newest first. Page 1 of 3.

Mar 2024
- 30 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 30 Mar · Routine
  We wish to inform you that pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company's Code .... (opens in a new tab)
Dec 2023
- 27 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 27 Dec · Routine
  We wish to inform you that pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company's Code .... (opens in a new tab)
Jun 2022
- 30 Jun · Routine
  Closure of trading window (opens in a new tab)
- 30 Jun · Routine
  Parenteral Drugs (India) Limited hereby submit the Notice of Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015. (opens in a new tab)
May 2022
Apr 2022
- 26 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
Mar 2022
- 31 Mar · Routine
  Closure of trading window from Thursday, March 31, 2022 till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2022. (opens in a new tab)
- 31 Mar · Routine
  Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of Company's Code of Conduct the trading .... (opens in a new tab)
Feb 2022
Jan 2022
- 14 Jan · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
- 14 Jan · Routine
  Parenteral Drugs (India) Limited hereby submits Confirmation Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the third quarter ended .... (opens in a new tab)
Nov 2021
- 15 Nov · Routine
  Publication of Unaudited Financial results for the Quarter and half year ended on 30th September, 2021 in newspaper (opens in a new tab)
- 15 Nov · Routine
  Disclosure regarding publication of Unaudited Financial Results for the Quarter and half year ended on 30th September, 2021 in Newspaper (opens in a new tab)
Oct 2021
- 14 Oct · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
- 14 Oct · Routine
  Parenteral Drugs (India) Limited hereby submits Confirmation Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
Sep 2021
Aug 2021
- 12 Aug · Routine
  Parenteral Drugs (India) Limited hereby submits copy of newspaper publication of Unaudited Financial Results for the Quarter Ended 30th June, 2021 (opens in a new tab)
- 12 Aug · Routine
  Copy of Newspaper Publication of Unaudited Financial Results for the Quarter ended 30th June , 2021 (opens in a new tab)
Jul 2021
Jun 2021
- 30 Jun · Routine
  Parenteral Drugs (India) Limited hereby submits Annual Secretarial Compliance Report under Regulation 24A of SEBI (LODR) Regulations, 2015 for the financial year ended 31st March, 2021 (opens in a new tab)
Apr 2021
Feb 2021
Jan 2021
- 29 Jan · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
- 29 Jan · Routine
  Parenteral Drugs (India) Limited hereby submits confirmation certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. (opens in a new tab)
Nov 2020
Oct 2020
- 23 Oct · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020 (opens in a new tab)